Assistant Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Harold R. Collard, MD
|
|
Give Review
Harold R. Collard practices Internal Medicine. He went to Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Harold R. Collard, MD is a published physician. He published 100 publications, including: 'Mutations in purine nucleoside phosphorylase deficiency.' He accepts all Medicare patients.
Publications
- Multidisciplinary Approach to Hypersensitivity Pneumonitis.
- House of Cards? Testing Fundamental Assumptions in Idiopathic Pulmonary Fibrosis Epidemiology.
- Acute exacerbation of idiopathic Pulmonary fibrosis: shifting the paradigm.
- Pharmacological treatment of idiopathic Pulmonary fibrosis: an update.
- Unified baseline and longitudinal mortality prediction in idiopathic Pulmonary fibrosis.
- Molecular Biomarkers in Idiopathic Pulmonary Fibrosis.
- Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic Pulmonary fibrosis.
- Open-Access Biorepository for Idiopathic Pulmonary Fibrosis: The Way Forward.
- Acute exacerbations complicating interstitial lung Disease.
- Endogenously Expressed IL-13Rα2 Attenuates IL-13-Mediated Responses but Does Not Activate Signaling in Human Lung Fibroblasts.
- Hot off the breath: a big step forward for idiopathic Pulmonary fibrosis.
- Idiopathic Pulmonary Fibrosis: CT and Risk of Death.
- Staging of idiopathic Pulmonary fibrosis: past, present and future.
- Effect of telomere length on survival in patients with idiopathic Pulmonary fibrosis: an observational cohort study with independent validation.
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis.
- Diagnosis of idiopathic Pulmonary fibrosis with high-resolution CT.
- Idiopathic Pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
- Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic Pulmonary fibrosis.
- Connective tissue disease related interstitial lung diseases and idiopathic Pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical tr...
- Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study.
- Predictors of mortality in rheumatoid arthritis-related interstitial lung Disease.
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.
- Future Directions in Idiopathic Pulmonary Fibrosis Research: An NHLBI Workshop Report.
- Acute exacerbation of idiopathic Pulmonary fibrosis associated with air pollution exposure.
- Rheumatoid Arthritis-associated Interstitial Lung Disease: Radiologic Identification of Usual Interstitial Pneumonia Pattern.
- Update on the diagnosis and classification of ILD.
- Pathogenesis of Idiopathic Pulmonary Fibrosis.
- Anti-acid treatment and disease progression in idiopathic Pulmonary fibrosis: an analysis of data from three randomised controlled trials.
- Treatment of idiopathic Pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
- Outcomes in systemic sclerosis-related lung Disease after lung transplantation.
- Genome-wide association study identifies multiple susceptibility loci for Pulmonary fibrosis.
- Prevalence and clinical significance of circulating autoantibodies in idiopathic Pulmonary fibrosis.
- Lung mast cell density defines a subpopulation of patients with idiopathic Pulmonary fibrosis.
- A multidimensional index and staging system for idiopathic Pulmonary fibrosis.
- Burden of Illness in Idiopathic Pulmonary Fibrosis.
- Reduced lung diffusion capacity in type 2 diabetes is independent of Heart failure.
- Risk prediction in idiopathic Pulmonary fibrosis.
- Depression is a common and Chronic comorbidity in patients with interstitial lung disease.
- Comprehensive care of the patient with idiopathic Pulmonary fibrosis.
- Gastroesophageal Reflux Therapy is Associated with Longer Survival in Idiopathic Pulmonary Fibrosis.
- COUGH PREDICTS PROGNOSIS IN IDIOPATHIC Pulmonary FIBROSIS.
- Primum non nocere: Safety in clinical trials for IPF.
- Depression and functional status are strongly associated with dyspnea in interstitial lung Disease.
- Viral infection in acute exacerbation of idiopathic Pulmonary fibrosis.
- Clinical course and prediction of survival in idiopathic Pulmonary fibrosis.
- Plasma biomarker profiles in acute exacerbation of idiopathic Pulmonary fibrosis.
- Pulmonary rehabilitation for interstitial lung disease.
- Management of dyspnea in interstitial lung Disease.
- The age of idiopathic Pulmonary fibrosis.
- Undifferentiated connective tissue Disease-associated interstitial lung Disease: changes in lung function.
- Does Chronic microaspiration cause idiopathic pulmonary fibrosis?
- Rheumatoid arthritis-associated interstitial lung Disease: the relevance of histopathologic and radiographic pattern.
- Obstructive sleep apnea is common in idiopathic Pulmonary fibrosis.
- Silicone injection causing acute Pneumonitis: a case series.
- Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response.
- Dyspnea in interstitial lung Disease.
- Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue Disease?
- In response to Silvestri.
- Sildenafil improves walk distance in idiopathic Pulmonary fibrosis.
- On beyond zebra: understanding rare Diseases.
- Anticoagulant therapy and idiopathic Pulmonary fibrosis.
- Current perspectives on the treatment of idiopathic Pulmonary fibrosis.
- Classification and natural history of the idiopathic Interstitial pneumonias.
- Nosocomial Pneumonia: state of the science.
- Clinical problem-solving. A perfect storm.
- Clinical and economic consequences of ventilator-associated Pneumonia: a systematic review.
- Subglottic secretion drainage for preventing ventilator-associated Pneumonia: a meta-analysis.
- Clinical problem-solving. Why "why" matters.
- Diffuse alveolar hemorrhage.
- Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic Pulmonary fibrosis.
- Prognosis in idiopathic Pulmonary fibrosis.
- Clinical problem-solving. Anatomy of a diagnosis.
- Changes in clinical and physiologic variables predict survival in idiopathic Pulmonary fibrosis.
- Prevention of ventilator-associated Pneumonia: an evidence-based systematic review.
- Demystifying idiopathic Interstitial pneumonia.
- Clinical problem-solving. Diagnosis still in question.
- Suspected acute exacerbation of idiopathic Pulmonary fibrosis as an outcome measure in clinical trials.
- How to build a biomarker: IL-7 and acute exacerbation of IPF.
- Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic Pulmonary fibrosis.
- An official ATS/ERS/JRS/ALAT statement: idiopathic Pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
- A controlled trial of sildenafil in advanced idiopathic Pulmonary fibrosis.
- Idiopathic Pulmonary fibrosis and pirfenidone.
- Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung Disease.
- Longitudinal Lung function in idiopathic NSIP: what are we missing?
- Idiopathic Pulmonary fibrosis and nonspecific interstitial pneumonia should stay separate.
- Acute exacerbations of idiopathic Pulmonary fibrosis.
- A practical guide for clinicians who treat patients with amiodarone: 2007.
- Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung Disease.
- Current diagnosis and management of idiopathic Pulmonary fibrosis: a survey of academic physicians.
- The clinical significance of histopathologic subgroups in idiopathic Interstitial pneumonia: is surgical lung biopsy essential?
- Neurofibromatosis-associated lung Disease: a case series and literature review.
- Patient experiences with Pulmonary fibrosis.
- Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic Pulmonary fibrosis.
- The role of N-linked carbohydrate residues in lymphokine-activated killer cell-mediated cytolysis.
- Mutations in purine nucleoside phosphorylase deficiency.
- Possible extrathymic development of nonfunctional T cells in a patient with complete DiGeorge syndrome.
- Treatment of idiopathic Pulmonary fibrosis: the rise and fall of corticosteroids.
- Lung biopsy in patients with usual Interstitial pneumonia.
- Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.
Schools
Duke University School Of Medicine
University Calif San Francisco
University Colo
Procedures Preformed
- Bronchoscopy
- Thoracentesis
Conditions Treated
- Asthma
- Bronchiectasis
- Bronchiolitis
- Bronchitis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
UCSF -
Duke University School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1740245380 | |
| NPPES Provider LastName | COLLARD | |
| NPPES Provider FirstName | HAROLD | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 26.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740245380 |
| Last Name Of The Provider | COLLARD |
| First Name Of The Provider | HAROLD |
| View All |
Similar Doctors
|
Dr. Fred B. Hom, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric R. Kwok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annie I. Loh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emerald M. Spencer, MD |
|
|
Dr. Homer A. Boushey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis S. Greenspan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua M. Galanter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Frank, MD |
|
|
Dr. Adithya Cattamanchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen C. Lazarus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy A. Lieberman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry Hollander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin M. Stechert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Ebinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Louisell, MD |
|
|
Dr. Donald L. McDonald, MD |